Pediatric Rehabilitation

Pediatric rehabilitation has been reshaped by disease-modifying therapies in neuromuscular disease and refined surgical and pharmacologic options for cerebral palsy. The track will cover the rehabilitative implications of onasemnogene abeparvovec (Zolgensma), risdiplam, and nusinersen in SMA, exon-skipping and gene therapy in DMD (delandistrogene moxeparvovec), and longitudinal motor outcomes. CP content includes selective dorsal rhizotomy patient selection, intrathecal baclofen pump management, and single-event multilevel surgery rehabilitation. Sessions will also address constraint-induced movement therapy in hemiplegic CP, pediatric power mobility provision, and transition-of-care models from pediatric to adult rehabilitation services.